Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
26 Leser
Artikel bewerten:
(0)

Global $167.9 Million Lactoferrin Market Analysis 2014-2017 & 2025

DUBLIN, July 13, 2017 /PRNewswire/ --

The "Lactoferrin Market Analysis By Function (Iron Absorption, Anti-inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, Antioxidant), By Application, By Region, And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The global lactoferrin market is expected to reach USD 167.9 million by 2025

Increasing demand for infant formula has been a major factor driving market growth. Utilization of lactoferrin has increased owing to the rising health concerns among consumers.

Lactoferrin is derived from the transferrin family and is a multifunctional protein. Transferrins are glycoproteins and are known to have the ability to control the free iron content in the human body, and bind them together. The transferrin family derivative is present in extensive quantities in various parts of the human body including, tears, nasal secretions, milk, and saliva.

The multifunctional protein helps to separate the free iron in the human body and also remove any content which promotes bacterial activity. The transferring family derivative helps to inhibit the bacterial growth by binding the lipopolysaccharides with bacterial walls and thus forming peroxides. Owing to this ability of the multifunctional protein, it is widely used in the healthcare sector for curing and preventing bacterial infections & diseases. The antibacterial function of lactoferrin is projected to show a high growth over the next eight years. The antibacterial function segment had a market share of 20.4% in 2016.

Infant formula application segment is expected to have a steady growth rate over the next eight years with an estimated CAGR of 8.1%. The multifunctional protein is the key component of human milk required for infants as they help in iron absorption and its transportation. Cow's milk contains the multifunctional protein in minute quantities of 0.1 mg/mL, whereas infants require it in the quantities of 2-3 mg/mL. Commercially produced infant formula with lactoferrin content has high iron absorption, antibacterial, and antioxidation properties. This factor is projected to propel the infant formula segment growth over the next eight years.

Further key findings from the report suggest:

  • The global lactoferrin demand was 255.0 tons in 2016 and is expected to grow at a CAGR of 8.1% from 2017 to 2025
  • Iron absorption emerged as the largest function segment in 2016 and is estimated to be worth 151.9 tons by 2025
  • Intestinal flora protection is anticipated to be the fastest growing function segment over the next eight years and is estimated to grow at a CAGR of 8.7%
  • The global lactoferrin demand in food & beverages application was valued at USD 19.7 million in 2016 and is anticipated to witness steady growth over the next eight years
  • Industry participants include Metagenics, Pharming Group N.V., Vitalus Nutrition Inc., Ingredia SA., MP Biomedicals, Glanbia Nutritionals, Farbest Brands, Fonterra Co-Operative Group Ltd., and ProHealth

Key Topics Covered:

1 Methodology and Scope

2 Executive Summary

3 Lactoferrin Market Variables, Trends & Scope

4 Lactoferrin Market: Function Estimates & Trend Analysis

5 Lactoferrin Market: Application Estimates & Trend Analysis

6 Lactoferrin Market: Regional Estimates & Trend Analysis

7 Competitive Landscape

8 Company Profiles

  • Metagenics
  • Pharming Group N.V.
  • Vitalus Nutrition Inc.
  • Westland Co-Operative Dairy Co. Ltd.
  • Synlait Milk Ltd.
  • Ingredia SA
  • MP Biomedicals
  • Tatura Milk Industries Ltd.
  • Glanbia Nutritionals
  • APS BioGroup
  • ProHealth
  • Fonterra Co-Operative Group Ltd.
  • Frabest Brands
  • Invitria
  • Milei GmbH

For more information about this report visit https://www.researchandmarkets.com/research/xjpxn6/lactoferrin

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.